Login to Your Account



'Favorable' Symphony Buyback Deal Sends Alexza Skyrocketing

By Jennifer Boggs


Wednesday, June 17, 2009
Shares of Alexza Pharmaceuticals Inc. shot up 51 percent on the company's plans to acquire Symphony Allegro, the joint venture with Symphony Capital LLC that has funded development of three Staccato programs for the past three years. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription